These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35335991)

  • 1. Effects of Injection Volume and Route of Administration on Dolutegravir In Situ Forming Implant Pharmacokinetics.
    Joiner JB; King JL; Shrivastava R; Howard SA; Cottrell ML; Kashuba ADM; Dayton PA; Benhabbour SR
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting injectable multipurpose prevention technology for prevention of HIV and unplanned pregnancy.
    Young IC; Pallerla A; Cottrell ML; Maturavongsadit P; Prasher A; Shrivastava R; De la Cruz G; Montgomery SA; Schauer A; Sykes C; Kashuba ADM; Benhabbour SR
    J Control Release; 2023 Nov; 363():606-620. PubMed ID: 37797892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive characterization of the effect of varying PLGA molecular weight blends on in situ forming implant behavior using ultrasound imaging.
    Solorio L; Olear AM; Hamilton JI; Patel RB; Beiswenger AC; Wallace JE; Zhou H; Exner AA
    Theranostics; 2012; 2(11):1064-77. PubMed ID: 23227123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-Ranging Plasma and Genital Tissue Pharmacokinetics and Biodegradation of Ultra-Long-Acting Cabotegravir In Situ Forming Implant.
    Young IC; Thorson AL; Shrivastava R; Sykes C; Schauer AP; Cottrell ML; Kashuba ADM; Benhabbour SR
    Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of PLGA
    Ibrahim TM; El-Megrab NA; El-Nahas HM
    Pharm Dev Technol; 2021 Sep; 26(7):709-728. PubMed ID: 34176433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Drug Physicochemical Properties on In-Situ Forming Implant Polymer Degradation and Drug Release Kinetics.
    Joiner JB; Prasher A; Young IC; Kim J; Shrivastava R; Maturavongsadit P; Benhabbour SR
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic Salt Additives Modulate the Acidic Microenvironment Around In Situ Forming Implants.
    Hopkins K; Wakelin E; Romick N; Kennedy J; Simmons E; Solorio L
    Ann Biomed Eng; 2023 May; 51(5):966-976. PubMed ID: 36454398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Treatment Efficacy of In Situ Forming Implants via Concurrent Delivery of Chemotherapeutic and Chemosensitizer.
    Jeganathan S; Budziszewski E; Hernandez C; Dhingra A; Exner AA
    Sci Rep; 2020 Apr; 10(1):6587. PubMed ID: 32313056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of poly (ϵ-caprolactone-co-DL-lactide) as a biodegradable material for in situ forming implants: evaluation of drug release and in vivo degradation.
    Zhang X; Zhang C; Zhang W; Meng S; Liu D; Wang P; Guo J; Li J; Guan Y; Yang D
    Drug Dev Ind Pharm; 2015 Feb; 41(2):342-52. PubMed ID: 24320881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ forming implants exposed to ultrasound enhance therapeutic efficacy in subcutaneous murine tumors.
    Jeganathan S; Budziszewski E; Bielecki P; Kolios MC; Exner AA
    J Control Release; 2020 Aug; 324():146-155. PubMed ID: 32389777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo study of thymosin alpha1 biodegradable in situ forming poly(lactide-co-glycolide) implants.
    Liu Q; Zhang H; Zhou G; Xie S; Zou H; Yu Y; Li G; Sun D; Zhang G; Lu Y; Zhong Y
    Int J Pharm; 2010 Sep; 397(1-2):122-9. PubMed ID: 20650309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new engineering process of biodegradable polymeric solid implants for ultra-long-acting drug delivery.
    Maturavongsadit P; Paravyan G; Kovarova M; Garcia JV; Benhabbour SR
    Int J Pharm X; 2021 Dec; 3():100068. PubMed ID: 33392498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-melanoma efficiency of the intratumoral injection of cucurbitacin-loaded sustained release carriers: in situ-forming implants.
    Guo J; Wang J; Cai C; Xu J; Yu H; Xu H; Xing T
    AAPS PharmSciTech; 2015 Aug; 16(4):973-85. PubMed ID: 25609378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injectable In-Situ Forming Depot Based on PLGA and PLGA-PEG-PLGA for Sustained-Release of Risperidone: In Vitro Evaluation and Pharmacokinetics in Rabbits.
    Rezaeian Shiadeh SN; Hadizadeh F; Khodaverdi E; Gorji Valokola M; Rakhshani S; Kamali H; Nokhodchi A
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Polymer Permeability and Solvent Removal Rate on
    Zhang X; Yang L; Zhang C; Liu D; Meng S; Zhang W; Meng S
    Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31658642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of injectable Rasagiline mesylate dual-controlled drug delivery system for the treatment of Parkinson's disease.
    Jiang Y; Zhang X; Mu H; Hua H; Duan D; Yan X; Wang Y; Meng Q; Lu X; Wang A; Liu W; Li Y; Sun K
    Drug Deliv; 2018 Nov; 25(1):143-152. PubMed ID: 29275639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of spermatogenesis by testosterone undecanoate-loaded injectable in situ-forming implants in adult male rats.
    Zhang XW; Zhang C; Zhang W; Yang D; Meng S; Wang P; Guo J; Liu DH
    Asian J Androl; 2016; 18(5):791-7. PubMed ID: 26459781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable polymeric solid implants for ultra-long-acting delivery of single or multiple antiretroviral drugs.
    Maturavongsadit P; Shrivastava R; Sykes C; Cottrell ML; Montgomery SA; Kashuba ADM; Rahima Benhabbour S
    Int J Pharm; 2021 Aug; 605():120844. PubMed ID: 34216767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an enhanced formulation for delivering sustained release of buprenorphine hydrochloride.
    Koocheki S; Madaeni SS; Niroomandi P
    Saudi Pharm J; 2011 Oct; 19(4):255-62. PubMed ID: 23960766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asenapine maleate in situ forming biodegradable implant: an approach to enhance bioavailability.
    Avachat AM; Kapure SS
    Int J Pharm; 2014 Dec; 477(1-2):64-72. PubMed ID: 25305379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.